BioSurface Engineering Technologies, Inc: Clinical Trials

3 trials sponsored by BioSurface Engineering Technologies, Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 3
Phase 23Unknown 3

Follow BioSurface Engineering Technologies, Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating Amplex Compared To Autograft Bone In Foot and Ankle Fusion Surgery
Amplex, Autograft bone - Arthritis
Phase 1 / Phase 2UnknownBioSurface Engineering Technologies, Inc242011-01-012012-03-09
Pilot Study to Assess Safety/Preliminary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2UnknownBioSurface Engineering Technologies, Inc222008-11-012012-03-09
Pilot Study to Assess Safety/Prelimary Effectiveness of Prefix in Subjects With Degenerative Disc Disease (DDD) Undergoing Spine Fusion Surgery
Prefix (AMPLEX) B2A Peptide Enhanced Ceramic Granules, Iliac crest autograft - Degenerative Disc Disease, Spondylolisthesis
Phase 1 / Phase 2UnknownBioSurface Engineering Technologies, Inc242008-11-012012-03-09

Conditions studied

Intervertebral Disc Degeneration (2)  ·  Spondylolisthesis (2)  ·  Arthritis (1)

Countries

Canada (2)  ·  United States (1)

Top investigators

David M Hooper, PhD (2)  ·  Brent Atkinson, PhD (1)  ·  Mark Glazebrook, MD (1)

Results publications

PMID 23463779